FDA NDC Directory · JSON-LD · Markdown

Daybue

NDC 63090-660 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nametrofinetide
Labeler / ManufacturerAcadia Pharmaceuticals Inc.
Marketing categoryNew Drug Application (innovator) · App NDA217026
Dosage form / routeSOLUTION · ORAL
Active ingredientsTROFINETIDE (200 mg/mL)
Marketing started20230310
Package count1

External sources

Source: openFDA. Public-domain (CC0).